|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.384 SEK | +0.73% |
|
+5.33% | -29.75% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.56% | 0.62% | 35.46x | 21.54x | 12.91x | |
| 2.03% | 2.12% | 28.11x | 7.07x | 6.45x | |
| 2.72% | 2.86% | 30.45x | 1357.72x | 7.46x | |
| 2.99% | 3.06% | 17.81x | 6.62x | 4.43x | |
| 1.75% | 1.85% | 23.78x | 5.57x | 4.98x | |
| 2.83% | 2.93% | 21.66x | 6.48x | 5.57x | |
| 3.51% | 3.41% | 14.26x | 6.25x | 5.31x | |
| 2.74% | 2.9% | 24.07x | 18.47x | 6.37x | |
| 2.39% | 2.48% | -48.15x | 8.49x | 5.84x | |
| Average | 2.39% | 2.47% | 16.38x | 159.80x | 6.59x | |
| Weighted average by Cap. | 1.95% | 2.03% | 24.24x | 176.58x | 8.02x |
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
